Abstract
Aim: The present study aims at explaining the epidemic situation in India for COVID-19 and forecasting the expected rise in the positive cases in India.
Objective: This study will be useful for Government authorities and Medical Practitioners in assessing the trends for India and preparing a combat plan with stringent measures. This research would also be useful in predicting outbreak numbers with greater precision for people involved in exploring this deadly disease.
Methods: We used the Support Vector Machine (SVM) to forecast and analyze the COVID-19 situations to predict future trends. On definite trail and model training, it was observed that the number of COVID cases will increase for the next four days.
Results: The SVM model predicted accurate results. The prediction accuracy seems to best fit and indicates the cases to rise in the next coming days. Confirmed cases and the SVM predictions are close to each other, thus proving the accuracy of the SVM predictions. It was inferred that the numbers of COVID-19 instances will rise if the same trend is followed.
Conclusion: The COVID-19 outbreak is exacerbated by secondary hospital transmission. Testing, particularly of those coming in with respiratory symptoms, is essential to isolate those in hospitals. A two-stage, pre-emptive testing is recommended in symptomatic older people immediately to reduce mortality. Immediate and on-going serological surveys are required to track the epidemic level. We are flying blind at the moment. The demand for the ventilators would be 1 million. The current supply in India is projected to range from 30 K to 50 K (the US has 160 K and is still running short). Health staff involved in treating COVID-19 patients also have to shield themselves using personal protection (i.e., masks and gowns) to save themselves from being infected. Thus, SVM model predictions will give a better insight into the growth of COVID-19 cases and, therefore, will allow the government of India to take adequate measures to restrain the issue at the earliest.
Keywords: COVID-19, SVM, stringent action, modelling, forecast, India.
Graphical Abstract
The Natural Products Journal
Title:Predicting the Cumulative Number of Cases of the COVID-19 Epidemic in India from Early Data
Volume: 11 Issue: 5
Author(s): Amit Kumar Thakur*, Rajesh Singh, Anita Gehlot, Prabin Kumar Das and Bishwajyoti Roy
Affiliation:
- Department of Mechanical Engineering, Lovely Professional University, Phagwara, Punjab,India
Keywords: COVID-19, SVM, stringent action, modelling, forecast, India.
Abstract:
Aim: The present study aims at explaining the epidemic situation in India for COVID-19 and forecasting the expected rise in the positive cases in India.
Objective: This study will be useful for Government authorities and Medical Practitioners in assessing the trends for India and preparing a combat plan with stringent measures. This research would also be useful in predicting outbreak numbers with greater precision for people involved in exploring this deadly disease.
Methods: We used the Support Vector Machine (SVM) to forecast and analyze the COVID-19 situations to predict future trends. On definite trail and model training, it was observed that the number of COVID cases will increase for the next four days.
Results: The SVM model predicted accurate results. The prediction accuracy seems to best fit and indicates the cases to rise in the next coming days. Confirmed cases and the SVM predictions are close to each other, thus proving the accuracy of the SVM predictions. It was inferred that the numbers of COVID-19 instances will rise if the same trend is followed.
Conclusion: The COVID-19 outbreak is exacerbated by secondary hospital transmission. Testing, particularly of those coming in with respiratory symptoms, is essential to isolate those in hospitals. A two-stage, pre-emptive testing is recommended in symptomatic older people immediately to reduce mortality. Immediate and on-going serological surveys are required to track the epidemic level. We are flying blind at the moment. The demand for the ventilators would be 1 million. The current supply in India is projected to range from 30 K to 50 K (the US has 160 K and is still running short). Health staff involved in treating COVID-19 patients also have to shield themselves using personal protection (i.e., masks and gowns) to save themselves from being infected. Thus, SVM model predictions will give a better insight into the growth of COVID-19 cases and, therefore, will allow the government of India to take adequate measures to restrain the issue at the earliest.
Export Options
About this article
Cite this article as:
Thakur Kumar Amit *, Singh Rajesh, Gehlot Anita , Das Kumar Prabin and Roy Bishwajyoti , Predicting the Cumulative Number of Cases of the COVID-19 Epidemic in India from Early Data, The Natural Products Journal 2021; 11 (5) . https://dx.doi.org/10.2174/2210315510999200813154206
DOI https://dx.doi.org/10.2174/2210315510999200813154206 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19
Current Medicinal Chemistry Engineering Approaches Toward Biological Information Integration at the Systems Level
Current Bioinformatics The Recovery of an Elderly Woman with Asthma and Diabetes from COVID-19 Infection: A Case Report
Infectious Disorders - Drug Targets Pharmacological Perspectives of Ayurvedic Herbs <i>viz. Alstonia scholaris</i> L., <i>Picrorhiza kurroa, Swertia chirata</i> and <i>Caesalpinia crista</i> Against COVID- 19: A Mini-Review
Mini-Reviews in Organic Chemistry Pattern and Age Distribution of COVID-19 on Pulmonary Computed Tomography
Current Medical Imaging New Analogues of Mycophenolic Acid
Mini-Reviews in Medicinal Chemistry SARS-CoV-2: An Insight into Detection Tools
Infectious Disorders - Drug Targets Forecasting of Covid-19 Cases Using Machine Learning Approach
Current Respiratory Medicine Reviews COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Clinical Spectrum, Geographical Variability of COVID-19, and its Implications
Coronaviruses Docking Studies with Multiple Molecular Targets Associated with SARSCoV- 2 for Drug Repurposing
Coronaviruses An Overview on COVID-19 Pandemic: from Discovery to Treatment
Infectious Disorders - Drug Targets Withdrawal Notice: Identification of the Interaction between Angiotensin-converting Enzyme Residues and Severe Acute Respiratory Syndrome Coronavirus 2
Current Pharmaceutical Design Meet Our Editorial Board Member:
Recent Patents on Anti-Infective Drug Discovery Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
Coronaviruses Coumarins and Quinolones as Effective Multiple Targeted Agents Versus Covid-19: An <i>In Silico</i> Study
Medicinal Chemistry Rhinovirus-Associated Wheeze During Infancy and Asthma Development
Current Respiratory Medicine Reviews Exploitation of Some Natural Products for the Prevention and/or Nutritional Treatment of SARS-CoV2 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Interaction Models of a Series of Oxadiazole-Substituted α-Isopropoxy Phenylpropanoic Acids Against PPARα and PPARγ: Molecular Modeling and Comparative Molecular Similarity Indices Analysis Studies
Protein & Peptide Letters Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals